MENU
+Compare
RENXF
Stock ticker: OTC
AS OF
Dec 24 closing price
Price
$0.08
Change
-$0.00 (-0.00%)
Capitalization
34.84M

RENXF Renalytix plc Forecast, Technical & Fundamental Analysis

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease... Show more

RENXF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for RENXF with price predictions
Dec 24, 2025

RENXF in upward trend: 10-day moving average broke above 50-day moving average on December 24, 2025

The 10-day moving average for RENXF crossed bullishly above the 50-day moving average on December 24, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

RENXF moved above its 50-day moving average on December 24, 2025 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (21.942). P/E Ratio (0.000) is within average values for comparable stocks, (105.648). RENXF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.394). Dividend Yield (0.000) settles around the average of (0.028) among similar stocks. P/S Ratio (7.087) is also within normal values, averaging (67.207).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. RENXF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RENXF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

View a ticker or compare two or three
RENXF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTEEF0.04N/A
N/A
Plaintree Systems Inc.
LYSFF5.00N/A
N/A
Leroy Seafood Group ASA
OBIIF32.17N/A
N/A
Obic Co. Ltd.
MHCUF19.44N/A
N/A
Flagship Communities Real Estate Investment Trust
QIMGF0.42-0.02
-3.54%
QUIMBAYA GOLD INC

Groups containing RENXF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RENXF
1D Price
Change %
RENXF100%
N/A
Health Services
category (403 stocks)
-0%
Poorly correlated
-0.57%
Services to the Health Industry
category (88 stocks)
-0%
Poorly correlated
-0.78%